OSP News

HAP Wants to Let You Know of The Chantix Drug Recall

Posted: 10/05/2021

On September 16, 2021, Pfizer issued a recall for all brand Chantix products for safety reasons. These products are being recalled due to presence of a nitrosamine contaminate that may be associated with a theoretical potential for increase in cancer risk in humans.

HAP sent a letter to all impacted members. We also sent a letter to prescribers with a list of their HAP patients who received Chantix after May 1, 2021.

Click here to read the full announcement.

We value your privacy. We use cookies and other technologies to keep the web site reliable and secure, tailor your experience, and measure web site performance, as described in our Privacy Policy.

x

OSP Technical Support